Solid organ transplants in HIV-infected patients

Area of Science:

• Transplantation immunology and infectious diseases.
• Clinical management of immunocompromised patients.

Background:

• Increasing demand for kidney and liver transplants among people with HIV.
• Antiretroviral therapy and infection management have improved outcomes for HIV patients.
• HIV infection is no longer an absolute contraindication for solid organ transplantation.

Purpose of the Study:

• To review selection criteria for HIV-infected patients undergoing liver or kidney transplantation.
• To discuss outcomes and special management considerations for these patients.
• To highlight challenges in post-transplant care for HIV-positive recipients.

Main Methods:

• Review of data from large, prospective, multi-center cohort studies.
• Analysis of outcomes in carefully selected HIV-infected solid organ transplant recipients.
• Examination of management strategies for post-transplant complications.

Main Results:

• Solid organ transplantation is safe in carefully selected HIV-infected individuals.
• Key challenges include preventing acute rejection, managing drug-drug interactions, and treating recurrent viral hepatitis.
• Successful transplantation is achievable with appropriate patient selection and management.

Conclusions:

• HIV-infected patients can safely undergo kidney and liver transplantation.
• Careful selection and specialized management are crucial for successful outcomes.
• Ongoing research and clinical practice should address the specific challenges in this population.